Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring
- PMID: 34492688
- PMCID: PMC8423459
- DOI: 10.1093/cid/ciaa1849
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring
Comment on
-
Vancomycin Advanced Therapeutic Drug Monitoring: Exercise in Futility or Virtuous Endeavor to Improve Drug Efficacy and Safety?Clin Infect Dis. 2021 May 18;72(10):e675-e681. doi: 10.1093/cid/ciaa1354. Clin Infect Dis. 2021. PMID: 32898221
References
-
- Dilworth TJ, Schulz LT, Rose WE. Vancomycin advanced therapeutic drug monitoring: an exercise in futility or virtuous endeavor to improve drug efficacy and safety? Clin Infect Dis 2021; 72:e675–81. - PubMed
-
- Lodise TP, Rosenkranz SL, Finnemeyer M, et al. The Emperor’s New Clothes: PRospective observational evaluation of the association between initial vancomycin exposure and failure rates among ADult HospitalizEd patients with methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). Clin Infect Dis 2020; 70:1536–45. - PMC - PubMed
-
- Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009; 49:507–14. - PubMed
